C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2007
12/04/2007	US7303907 Transmissible spongiform encephalopathy agent inactivated by exposing the TSE agent to a thermostable proteolytic enzyme at elevated temperatures; infectivity determined by detection of dimers of prion protein
12/04/2007	US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R
12/04/2007	US7303895 Choline transport like (CTL) membrane proteins involved in choline transport
12/04/2007	US7303891 Method of detecting Lawsonia intracellularis antibodies
12/04/2007	US7303890 Proteins, genes encoding them and method of using the same
12/04/2007	US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007	US7303750 Methods to improve immunogenicity of antigens and specificity of antibodies
12/04/2007	US7303740 Determining whether or not mammary gland sodium/iodide symporter (mgNIS) is expressed in breast tissue of the subject, whereinexpression of mgNIS in the breast tissue is detected using an antibody, specific for mgNIS, expression of mgNIS in the breast tissue of is indicative of breast cancer presence
12/04/2007	CA2395453C Plant lesion formation suppressing gene, spl7 and use thereof
12/04/2007	CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
12/04/2007	CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007	CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
12/04/2007	CA2224724C Subunit vaccine against flavivirus infection
11/2007
11/29/2007	WO2007137279A2 Herv-k antigens, antibodies, and methods
11/29/2007	WO2007136892A2 Engineered antibody-stress protein fusions
11/29/2007	WO2007136764A2 A cmos linear voltage/current dual-mode imager
11/29/2007	WO2007136525A2 Chimeric monoclonal antibody
11/29/2007	WO2007136327A1 A method of producing igg
11/29/2007	WO2007135684A2 Method of treatment of anti-cd4 autoimmunity
11/29/2007	WO2007134876A2 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY
11/29/2007	WO2007134539A1 Antibody to autoantigen and/or species high conservation antigen and its preparing method
11/29/2007	WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application
11/29/2007	WO2007134350A2 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases
11/29/2007	WO2007113172A3 Antibodies against amyloid-beta peptide
11/29/2007	WO2007111931A3 Compositions and methods relating to modulation of immune system components
11/29/2007	WO2007106744A3 Anti-5t4 antibodies and uses thereof
11/29/2007	WO2007103288A3 Engineered antibody drug conjugates
11/29/2007	WO2007101021A3 Humanized anti-ghrelin antibodies
11/29/2007	WO2007100248A3 Adir related polymorphisms and applications thereof
11/29/2007	WO2007097810A3 Treatment for antiphospholipid-syndrome-related pregnancy complications
11/29/2007	WO2007090872A3 Antibodies against secreted fri zzled related protein-4 (sfrp-4 )
11/29/2007	WO2007089578A3 Method for selecting phosphate binder and its uses thereof
11/29/2007	WO2007084977A3 Low hemoglobin concentration cell percentage and method of use in detection of iron deficiency
11/29/2007	WO2007081978A3 Modulators of hepatocyte growth factor / c-met activity
11/29/2007	WO2007080392A3 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor
11/29/2007	WO2007070432A3 Binding proteins specific for insulin-like growth factors and uses thereof
11/29/2007	WO2007068750A3 Immunoglobulins directed against nogo
11/29/2007	WO2007067992A3 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
11/29/2007	WO2007051164A3 Toll like receptor 3 modulators, methods and uses
11/29/2007	WO2005044196A3 Novel modulators of amyloid-beta production and uses thereof
11/29/2007	US20070276133 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
11/29/2007	US20070276129 Modular molecular clasps and uses thereof
11/29/2007	US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007	US20070275873 Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting
11/29/2007	US20070275481 Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis
11/29/2007	US20070275464 Chitin Oligosaccharide Elicitor-Binding Proteins
11/29/2007	US20070275460 Immunogllobulin for use in tissue directed antibody dependent cell-mediated phagocytosis and/or antibody dependent cell-mediated cytotoxicity (ADCC) treatment of cancer, inflammation and cardiovascular disease; immunotherapeutics
11/29/2007	US20070275448 Methods For Obtaining Optically Active Epoxides And Vicinal Diols From Meso-Epoxides
11/29/2007	US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007	US20070275427 Method of Detecting Allergen
11/29/2007	US20070275420 Method For Detecting Prognosis Of Cancer
11/29/2007	US20070275419 Tumor tag and the use thereof
11/29/2007	US20070275418 Immunoglobulin for detecting fetal red blood cells in maternal blood; diagnosing chromosomal or genetic defects in developing fetus
11/29/2007	US20070275416 Affinity marker for purification of proteins
11/29/2007	US20070275410 Methods and Compositions Relating to Modulation of Gpcr Signaling
11/29/2007	US20070275409 detecting an amount of anti-Neu5Gc specific antibodies in a fluid sample such as food and clinical specimens
11/29/2007	US20070275391 Novel g-protein coupled receptors and dna sequences thereof
11/29/2007	US20070275384 Assessing human predisposition to a febrile seizure disorder
11/29/2007	US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007	US20070275005 Use of Lipopeptides for Activating T Lymphocytes Through the Skin
11/29/2007	US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007	US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis
11/29/2007	US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007	US20070274996 IL-4R antagonists; allergies and asthma
11/29/2007	US20070274995 Cardiotrophin-1 compositions and methods for the treatment of tumor
11/29/2007	US20070274994 Virulence-Associated Adhesins
11/29/2007	US20070274993 Immunocompetent Cell Activation Inhibitor and Use Thereof
11/29/2007	US20070274990 Novel Therapeutic Targets in Cancer
11/29/2007	US20070274989 Methods and Compositions for the Prevention and Treatment of Sepsis
11/29/2007	US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007	US20070274987 Expression of the cysteine protease legumain in vascular and inflammatory diseases
11/29/2007	US20070274986 Compositions comprising anti-CCR5 antibody
11/29/2007	US20070274985 Antibody
11/29/2007	US20070274982 Anti-EpCam Immunoglobulins
11/29/2007	US20070274981 Fibroblast Growth Factor Receptor-1 Inhibitors and Methods of Treatment Thereof
11/29/2007	US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/29/2007	US20070274915 Modulation Of Anergy And Methods For isolating Anergy-Modulating Compounds
11/29/2007	US20070274912 Histone Modifications as Binary Switches Controlling Gene Expression
11/29/2007	CA2653052A1 Treatment of protein misfolding
11/29/2007	CA2652886A1 High affinity human and humanized anti-.alpha.5.beta.1 integrin function blocking antibodies with reduced immunogenicity
11/29/2007	CA2652870A1 Treatment of cancer with anti-il-1a antibodies
11/29/2007	CA2652538A1 Fusion proteins, uses thereof and processes for producing same
11/29/2007	CA2649722A1 Use of an antibody
11/29/2007	CA2637988A1 Anti-fgf19 antibodies and methods using same
11/28/2007	EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007	EP1860189A1 Human gene
11/28/2007	EP1860188A2 Human cytokine receptor
11/28/2007	EP1860187A1 Apo-2 receptor
11/28/2007	EP1860186A2 Method for distinguishing mesenchymal stem cells using different markers
11/28/2007	EP1860184A1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide
11/28/2007	EP1860120A1 Method for improving antibody
11/28/2007	EP1860119A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
11/28/2007	EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007	EP1860117A2 Anti-bacterial vaccine compositions
11/28/2007	EP1859063A2 Replikin peptides and uses thereof
11/28/2007	EP1858929A1 Diagnosis of prostate cancer
11/28/2007	EP1858928A2 Anti-m-csf antibody compositions having reduced levels of endotoxin
11/28/2007	EP1858927A2 Methods and uses of antibodies in the purification of interferon
11/28/2007	EP1858926A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/28/2007	EP1858925A2 Antibodies and fc fusion proteins with altered immunogenicity

1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1494